Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy (Q48162545)

9 February 2018

title

Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy (English)

1 reference

9 February 2018

author name string

Christensen JD

1

1 reference

9 February 2018

Yurgelun-Todd DA

2

1 reference

9 February 2018

Babb SM

3

1 reference

9 February 2018

Gruber SA

4

1 reference

9 February 2018

Cohen BM

5

1 reference

9 February 2018

Renshaw PF

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 July 1999

1 reference

9 February 2018

published in

Brain Research

1 reference

9 February 2018

volume

834

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

1-5

1 reference

9 February 2018

Quantitation of dexfenflurainine/d‐norfenfluramine concentration in primate brain using 19F NMR spectroscopy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Valvular heart disease associated with fenfluramine-phentermine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Dexfenfluramine neurotoxicity in brains of non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Therapy for obesity--today and tomorrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Dexfenfluramine. Its place in weight control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

Dexfenfluramine, fluoxetine, and weight loss among female carbohydrate cravers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901441-9

10.1016/S0006-8993(99)01441-9

7 January 2021

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018